Synthetic oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs) and modified analogs as novel anticancer therapeutics

H Wang, E Rayburn, R Zhang - Current pharmaceutical design, 2005 - ingentaconnect.com
Oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs)
activate the host immune system, leading to innate and acquired immune responses. The …

Adjuvant-loaded spiky gold nanoparticles for activation of innate immune cells

J Nam, S Son, JJ Moon - Cellular and molecular bioengineering, 2017 - Springer
Introduction Gold nanoparticles are versatile carriers for delivery of biomacromolecules.
Here, we have developed spiky gold nanoparticles (SGNPs) that can efficiently deliver …

A single decoy oligodeoxynucleotides targeting multiple oncoproteins produces strong anticancer effects

H Gao, J Xiao, Q Sun, H Lin, Y Bai, L Yang, B Yang… - Molecular …, 2006 - ASPET
Cancer in general is a multifactorial process. Targeting a single factor may not be optimal in
therapy, because single agents are limited by incomplete efficacy and dose-limiting adverse …

CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy

HC Chaung - International immunopharmacology, 2006 - Elsevier
The genomes of bacterial and viral DNA contain a much higher frequency of unmethylated
CpG dinucleotides than those of vertebrates. This difference in genome structure allows the …

Impact of secondary structure of toll-like receptor 9 agonists on interferon alpha induction

D Yu, MR Putta, L Bhagat, M Dai, D Wang… - Antimicrobial agents …, 2008 - Am Soc Microbiol
Oligodeoxynucleotides containing a CpG motif and double-or multistranded structure-
forming sequences act as agonists of Toll-like receptor 9 (TLR9) and induce high levels of …

In vitro and in vivo stimulation of toll-like receptor 9 by CpG oligodeoxynucleotides incorporated into polypod-like DNA nanostructures

Y Takahashi, T Maezawa, Y Araie, Y Takahashi… - Journal of …, 2017 - Elsevier
Abstract Cytosine-phosphate-guanine (CpG) DNA is known to increase the potency of
vaccines. Here, in vitro and in vivo stimulation of toll-like receptor 9 by CpG DNA …

Self-stabilized CpG DNAs optimally activate human B cells and plasmacytoid dendritic cells

YP Cong, SS Song, L Bhagat, RK Pandey, D Yu… - Biochemical and …, 2003 - Elsevier
We recently showed that 5′-terminal secondary structures in CpG DNA affect activity
significantly more than those at the 3′-end [Biochem. Biophys. Res. Commun. 306 (2003) …

Cationic polymers that enhance the performance of HbsAg DNA in vivo

GW Bos, T Kanellos, DJA Crommelin, WE Hennink… - Vaccine, 2004 - Elsevier
In this paper, different cationic polymers were investigated as a DNA delivery system both in
vitro in dendritic and muscle cells and in vivo, in a murine model. Expression of the reporter …

Chimeric immunomodulatory compounds and methods of using the same—IV

KL Fearon, D Dina, SF Tuck - US Patent 8,114,418, 2012 - Google Patents
IYXQQOMXWUAAOK-JJSXZHHUSA-N 2-[(2S, 3S, 4R, 5R)-5-(6-aminopurin-9-yl)-3, 4-
dihydroxyoxolan-2-yl]-1-[4-(bromomethyl) phenyl]-2-hydroxyethanone Chemical compound …

CpG oligodeoxynucleotides with double stem-loops show strong immunostimulatory activity

L Yang, X Wu, M Wan, Y Yu, Y Yu, L Wang - International …, 2013 - Elsevier
Based on the current understanding of TLR9 recognition of CpG ODN, we have tried to
design a series of CpG ODNs that display double stem-loops when being analyzed for their …